LH
NYSEHealthcareLoading…
Labcorp Holdings Inc. Common Stock
Sector: Healthcare•United States•Market Cap: $22.1B
Related News
Latest stories connected to LH
- RS 74Why Is Labcorp (LH) Down 4.6% Since Last Earnings Report?Zacks Investment Research•Mar 19, 2026•Original source
- RS 74Labcorp Holdings (LH) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research•Mar 6, 2026•Original source
Financials
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Revenue | 13.95B | 13.01B | 12.16B | 11.86B | 13.14B | 13.98B | 11.55B | 11.33B | 10.44B | 9.64B |
| Cost of Revenue | 10.22B | 9.38B | 8.80B | 8.15B | 8.14B | 9.03B | 8.30B | 8.16B | 6.98B | 6.46B |
| Gross Profit | 3.73B | 3.62B | 3.36B | 3.71B | 4.99B | 4.95B | 3.25B | 3.18B | 3.46B | 3.18B |
| Research and Development Expenses | 0 | 0 | 2.00M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General and Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling and Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General and Administrative Expenses | 2.22B | 2.23B | 2.02B | 2.00B | 1.69B | 1.73B | 1.62B | 1.57B | 1.81B | 1.63B |
| Other Expenses | 0 | 307.70M | 615.90M | 275.80M | 253.50M | 778.10M | 243.20M | 167.70M | -7.60M | 2.60M |
| Operating Expenses | 2.22B | 2.54B | 2.64B | 2.27B | 1.94B | 2.51B | 1.87B | 1.80B | 2.03B | 1.81B |
| Cost and Expenses | 12.44B | 11.92B | 11.44B | 10.43B | 10.09B | 11.53B | 10.17B | 9.96B | 9.01B | 8.27B |
| Net Interest Income | -208.90M | -208.30M | -199.60M | -179.80M | -211.80M | -207.40M | -240.70M | -244.20M | -235.10M | -219.10M |
| Interest Income | 15.20M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 224.10M | 208.30M | 199.60M | 179.80M | 211.80M | 207.40M | 240.70M | 244.20M | 235.10M | 219.10M |
| Depreciation and Amortization | 681.10M | 643.50M | 577.30M | 537.20M | 577.00M | 624.70M | 577.20M | 552.10M | 533.20M | 499.20M |
| EBITDA | 2.01B | 1.81B | 1.35B | 1.95B | 3.68B | 3.25B | 2.12B | 2.06B | 1.85B | 1.81B |
| EBIT | 1.33B | 1.17B | 768.50M | 1.42B | 3.10B | 2.43B | 1.35B | 1.51B | 1.31B | 1.32B |
| Non Operating Income Excluding Interest | 184.60M | -81.10M | -42.90M | 19.30M | -50.80M | 18.90M | -15.40M | -186.80M | -7.40M | -6.60M |
| Operating Income | 1.52B | 1.09B | 725.60M | 1.44B | 3.05B | 2.45B | 1.33B | 1.33B | 1.36B | 1.31B |
| Total Other Income Expenses Net | -408.70M | -127.20M | -156.70M | -199.10M | -161.00M | -226.30M | -225.30M | -57.40M | -227.70M | -206.90M |
| Income Before Tax | 1.11B | 959.50M | 568.90M | 1.24B | 2.89B | 2.22B | 1.10B | 1.27B | 1.13B | 1.11B |
| Income Tax Expense | 229.80M | 212.40M | 188.50M | 233.90M | 690.00M | 662.10M | 280.00M | 384.40M | -139.10M | 372.30M |
| Net Income From Continuing Operations | 877.70M | 747.10M | 380.40M | 1.00B | 2.20B | 1.56B | 824.90M | 883.90M | 1.23B | 733.20M |
| Net Income From Discontinued Operations | 0 | 0 | 38.80M | 277.10M | 181.90M | 0 | 0 | 0 | 0 | 0 |
| Other Adjustments To Net Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | 877.70M | 746.00M | 379.20M | 1.00B | 2.38B | 1.56B | 824.90M | 883.90M | 1.27B | 733.20M |
| Net Income Deductions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrom Line Net Income | — | — | — | — | — | — | — | — | — | — |
| EPS | 10.54 | 8.89 | 4.8 | 14.04 | 24.58 | 15.99 | 8.41 | 8.71 | 12.39 | 7.14 |
| EPS Diluted | 10.46 | 8.84 | 4.77 | 13.96 | 24.38 | 15.88 | 8.36 | 8.61 | 12.21 | 7.02 |
| Weighted Average SHS Out | 83.20M | 83.90M | 87.10M | 91.10M | 96.70M | 97.30M | 97.90M | 101.40M | 102.40M | 102.50M |
| Weighted Average SHS Out Dil | 83.80M | 84.40M | 87.60M | 91.60M | 97.50M | 98.00M | 98.60M | 102.60M | 103.90M | 104.30M |
| Fiscal Year (FMP) | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K |
| Gross Profit Margin | 0.27 | 0.28 | 0.28 | 0.31 | 0.38 | 0.35 | 0.28 | 0.28 | 0.33 | 0.33 |
| R&D to Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A to Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Burden | 0.83 | 0.82 | 0.74 | 0.87 | 0.93 | 0.91 | 0.82 | 0.84 | 0.86 | 0.84 |
| EBIT Margin | 0.1 | 0.09 | 0.06 | 0.12 | 0.24 | 0.17 | 0.12 | 0.13 | 0.13 | 0.14 |
| EBITDA Margin | 0.14 | 0.14 | 0.11 | 0.16 | 0.28 | 0.23 | 0.18 | 0.18 | 0.18 | 0.19 |
| EBT per EBIT | 0.73 | 0.88 | 0.78 | 0.86 | 0.95 | 0.91 | 0.83 | 0.96 | 0.83 | 0.84 |
| Effective Tax Rate | 0.21 | 0.22 | 0.33 | 0.19 | 0.24 | 0.3 | 0.25 | 0.3 | -0.12 | 0.34 |
| Tax Burden | 0.79 | 0.78 | 0.73 | 1.03 | 0.82 | 0.7 | 0.75 | 0.7 | 1.12 | 0.66 |
| Cont. Operations Profit Margin | 0.06 | 0.06 | 0.03 | 0.08 | 0.17 | 0.11 | 0.07 | 0.08 | 0.12 | 0.08 |
| Bottom Line Profit Margin | 0.06 | 0.06 | 0.03 | 0.11 | 0.18 | 0.11 | 0.07 | 0.08 | 0.12 | 0.08 |
| Operating Cycle | 78.24 | 78.02 | 82.68 | 82.51 | 100.75 | 95.88 | 74.73 | 70.6 | 76.49 | 69.08 |
| Fwd PEG Ratio | 1.28 | 0.3 | -0.72 | -0.34 | 0.2 | 0.12 | -5.01 | -0.42 | 0.15 | 0.25 |
| Earnings Yield | 0.04 | 0.04 | 0.02 | 0.07 | 0.09 | 0.09 | 0.06 | 0.08 | 0.09 | 0.06 |
| Income Quality | 1.87 | 2.13 | 3.5 | 1.95 | 1.31 | 1.37 | 1.75 | 1.48 | 1.15 | 1.6 |